Opalmon

Opalmon

Manufacturer:

Ono Pharmaceutical

Distributor:

DKSH

Marketer:

Meiji
Concise Prescribing Info
Contents
Limaprost alfadex
Indications/Uses
Improvement of various ischemic symptoms eg, ulcer, pain & feeling of coldness associated w/ thromboangiitis obliterans. Improvement of subjective symptoms (pain & numbness of lower legs) & gait ability associated w/ acquired lumbar spinal canal stenosis (in patients w/ bilateral intermittent claudication showing normal SLR test result).
Dosage/Direction for Use
Adult Improvement of various ischemic symptoms eg, ulcer, pain & feeling of coldness associated w/ thromboangiitis obliterans 30 mcg daily in 3 divided doses. Improvement of subjective symptoms (pain & numbness of lower legs) & gait ability associated w/ acquired lumbar spinal canal stenosis (in patients w/ bilateral intermittent claudication showing normal SLR test result) 15 mcg daily in 3 divided doses.
Administration
May be taken with or without food.
Special Precautions
Patients w/ bleeding tendency or under treatment w/ antiplatelets, thrombolytics or anticoagulants; severe lumbar spinal canal stenosis.
Adverse Reactions
Stomach discomfort, rash, headache, diarrhea.
Drug Interactions
May accelerate bleeding tendency w/ antiplatelets eg, aspirin, ticlopidine, cilostazol, thrombolytics eg, urokinase, anticoagulants eg, heparin, warfarin.
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AX - Other antithrombotic agents ; Used in the treatment of thrombosis.
B01AC - Platelet aggregation inhibitors excl. heparin ; Used in the treatment of thrombosis.
Presentation/Packing
Form
Opalmon tab 5 mcg
Packing/Price
210's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in